GVK Biosciences Pvt Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:GVK Biosciences Pvt Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013932
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
GVK Biosciences Pvt Ltd (GVK BIO) is a contract research organization that offers contract manufacturing and research services. The organization provides services such as discovery services, integrated programs, clinical development, contract manufacturing, formulations and informatics. It provides distribution assays, animal models, assay development and screening, regulatory affairs services, report writing services, clinical operations services, clinical pharmacology, clinical research, clinical trial outcome database, and others. GVK BIO offers contract research services to its clientele from various sectors including pharmaceutical, agrochemical, electronics, biotechnology and academics. The organization operates through offices in India, the US and the Netherlands. GVK BIO is headquartered in Hyderabad, Telangana, India.

GVK Biosciences Pvt Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
GVK Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
GVK Biosciences Pvt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
GVK Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
GVK Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
GVK Biosciences Pvt Ltd, Medical Devices Deals, 2011 to YTD 2017 9
GVK Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
GVK Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Aragen Bioscience Raises US$2.7 Million In Venture Financing 11
Private Equity 12
ChrysCapital Management Acquires 10% stake in GVK Bio 12
Partnerships 13
Medivir Enters into Research Agreement with GVK Biosciences 13
GVK Biosciences Forms Joint Venture with Takeda Pharma 14
Aragen Bioscience Enters Into Co-Development Agreement With Innovent Biologics For Biotherapeutic Products 15
GVK Biosciences Enters Into Research Agreement With Endo Pharma 16
GVK Biosciences Enters Into Agreement With Onconova Therapeutics To Develop New Cancer Drugs 17
GVK Biosciences Enters Into Drug Discovery Agreement With Moulder Center for Drug Discovery Research 18
Licensing Agreements 19
Aragen Bioscience Enters into Licensing Agreement with ProteoNic Biotech 19
University Of Dundee Enters Into Licensing Agreement With GVK Biosciences For Gostar 20
GVK Biosciences Extends Licensing Agreement With Astellas Pharma 21
Acquisition 22
GVK Biosciences to Acquire Vanta Bioscience for USD5 Million 22
GVK Biosciences Acquires Remaining 6.12% Stake in Inogent Labs from Dai-Ichi Karkaria 23
GVK Biosciences Acquires Aragen Bioscience, Contract Research Organization 24
GVK Biosciences Plans To Acquire Spectrum Biosciences 25
GVK Biosciences Pvt Ltd – Key Competitors 26
GVK Biosciences Pvt Ltd – Key Employees 27
GVK Biosciences Pvt Ltd – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
GVK Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Key Facts 2
GVK Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
GVK Biosciences Pvt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
GVK Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
GVK Biosciences Pvt Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
GVK Biosciences Pvt Ltd, Medical Devices Deals, 2011 to YTD 2017 9
GVK Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Aragen Bioscience Raises US$2.7 Million In Venture Financing 11
ChrysCapital Management Acquires 10% stake in GVK Bio 12
Medivir Enters into Research Agreement with GVK Biosciences 13
GVK Biosciences Forms Joint Venture with Takeda Pharma 14
Aragen Bioscience Enters Into Co-Development Agreement With Innovent Biologics For Biotherapeutic Products 15
GVK Biosciences Enters Into Research Agreement With Endo Pharma 16
GVK Biosciences Enters Into Agreement With Onconova Therapeutics To Develop New Cancer Drugs 17
GVK Biosciences Enters Into Drug Discovery Agreement With Moulder Center for Drug Discovery Research 18
Aragen Bioscience Enters into Licensing Agreement with ProteoNic Biotech 19
University Of Dundee Enters Into Licensing Agreement With GVK Biosciences For Gostar 20
GVK Biosciences Extends Licensing Agreement With Astellas Pharma 21
GVK Biosciences to Acquire Vanta Bioscience for USD5 Million 22
GVK Biosciences Acquires Remaining 6.12% Stake in Inogent Labs from Dai-Ichi Karkaria 23
GVK Biosciences Acquires Aragen Bioscience, Contract Research Organization 24
GVK Biosciences Plans To Acquire Spectrum Biosciences 25
GVK Biosciences Pvt Ltd, Key Competitors 26
GVK Biosciences Pvt Ltd, Key Employees 27
GVK Biosciences Pvt Ltd, Other Locations 28
GVK Biosciences Pvt Ltd, Subsidiaries 28

★海外企業調査レポート[GVK Biosciences Pvt Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Verax Biomedical Inc-製薬・医療分野:企業M&A・提携分析
    Summary Verax Biomedical Inc (Verax) is a medical device company that develops rapid tests for the detection of bacterial contaminants in tissues for transplantation, blood components, and cellular therapies. The company’s products comprise platelet pgd test, red cell pgd test and cell therapy PGD t …
  • Luminex Corp (LMNX)-医療機器分野:企業M&A・提携分析
    Summary Luminex Corp (Luminex) is a medical devices company which develops, manufactures and markets proprietary biological testing technologies. The company offers wide range of products including instruments, assays, reagents and accessories, software and replacement parts. Its proprietary technol …
  • American States Water Company (AWR):企業の財務・戦略的SWOT分析
    Summary American States Water Company (AWR) is a utility service provider that offers water, wastewater and electric services. The utility provides operation, construction management and maintenance services for water and wastewater systems located on military bases across the US. It offers water se …
  • Volkswind GmbH-エネルギー分野:企業M&A・提携分析
    Summary Volkswind GmbH (Volkswind), a subsidiary of Axpo Holding AG, is an independent renewable power producer. It undertakes the planning, development, construction and operations of wind power plants. Volkswind builds wind farms with wind turbines from various suppliers including Seimens, Enercon …
  • SMART Medical Systems Ltd-医療機器分野:企業M&A・提携分析
    Summary Smart Medical Systems Ltd (Smart) is a medical device company that develops and manufactures medical equipment in the field of gastroenterology and GI endoscopy. The company offers products such as inflation systems, platform, naviaid ABC, G-eye, naviaid AB, future naviaid products, controll …
  • Alabama Municipal Electric Authority:企業の発電所・SWOT分析2018
    Alabama Municipal Electric Authority - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Whole Foods Market Inc:戦略・SWOT・企業財務分析
    Whole Foods Market Inc - Strategy, SWOT and Corporate Finance Report Summary Whole Foods Market Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Boryung Medience Corporation:企業の戦略・SWOT・財務情報
    Boryung Medience Corporation - Strategy, SWOT and Corporate Finance Report Summary Boryung Medience Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • SYNNEX Corp (SNX):企業の財務・戦略的SWOT分析
    SYNNEX Corp (SNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Fifth Street Finance Corp.:企業のM&A・事業提携・投資動向
    Fifth Street Finance Corp. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fifth Street Finance Corp. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Omron Corp (6645):企業の財務・戦略的SWOT分析
    Omron Corp (6645) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • United Biscuits (UK) Ltd:企業の戦略・SWOT・財務分析
    United Biscuits (UK) Ltd - Strategy, SWOT and Corporate Finance Report Summary United Biscuits (UK) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Nonin Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Nonin Medical Inc (Nonin) is a medical device company that provides medical monitoring solutions. The company provides noninvasive physiological monitoring devices for health professionals and consumers. Its products include pulse oximeters and sensors, regional oximeters and sensors, finger …
  • Pernod Ricard SA (RI):企業の財務・戦略的SWOT分析
    Pernod Ricard SA (RI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • QuickLogic Corp (QUIK):企業の財務・戦略的SWOT分析
    QuickLogic Corp (QUIK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Pan American Silver Corp:企業の戦略・SWOT・財務情報
    Pan American Silver Corp - Strategy, SWOT and Corporate Finance Report Summary Pan American Silver Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Nokia Corp (NOKIA):企業の財務・戦略的SWOT分析
    Nokia Corp (NOKIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • LEO Pharma AS-医療機器分野:企業M&A・提携分析
    Summary LEO Pharma A/S (LEO Pharma) is a research-based pharmaceutical company. It undertakes the discovery, development, manufacture and commercialization of pharmaceuticals in the therapeutic areas dermatology and thrombosis. The company focuses on the treatment of diseases such as psoriasis, ecze …
  • Petroleos de Venezuela SA-エネルギー分野:企業M&A・提携分析
    Summary Petroleos de Venezuela SA (PDVSA) is a state-owned oil and gas company. It plans, coordinates, supervises, and controls the activities in the entire oil and gas value chain. The company explores for and develops oil and other hydrocarbons; refines, trades, and supplies that in domestic and o …
  • Investment Technology Group, Inc.:企業の戦略・SWOT・財務分析
    Investment Technology Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Investment Technology Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆